CVI Investments, Inc. - 11 Nov 2025 SCHEDULE 13G Report for Salarius Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (SLRX)

Filing Manager
CVI Investments, Inc.
Reporting Manager
CVI Investments, Inc.
Security
Salarius Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
SLRX
Shares outstanding
3,661,606 shares
Disclosed Ownership
362,499 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
18 Nov 2025, 11:53:37 UTC
Date of event
11 Nov 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"CVI Investments, Inc. disclosed 9.9% ownership in Salarius Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (SLRX) on 11 Nov 2025."

Quick Takeaways

  • CVI Investments, Inc. filed SCHEDULE 13G for Salarius Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (SLRX).
  • Disclosed ownership: 9.9%.
  • Date of event: 11 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 18 Nov 2025, 11:53.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
CVI Investments, Inc. 9.9% 362,499 0 362,499 /s/ Sarah Travis Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Heights Capital Management, Inc. 9.9% 362,499 0 362,499 /s/ Sarah Travis Sarah Travis, Assistant General Counsel and Assistant Secretary

Sponsored